Full Text View
Tabular View
Study Results
Related Studies
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
This study has been completed.
Study NCT00766363   Information provided by EnVivo Pharmaceuticals, Inc.

First Received on October 1, 2008.   Last Updated on April 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial